Narat Srivali: Chronic Preoperative Corticosteroid Use Associated with 51% Higher Postoperative VTE Risk
Narat Srivali, Assistant Professor at Duke University Medical Center, shared a post on LinkedIn:
“I’m pleased to share that our systematic review and meta-analysis, ‘Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk,’ has been accepted in Thrombosis and Haemostasis.
Chronic corticosteroid use is common among patients undergoing surgery, yet its specific relationship with postoperative venous thromboembolism (VTE) had not previously been quantified systematically.
Across 9 retrospective cohort studies including 2,678,513 surgical patients – including 97,201 chronic corticosteroid users – we found that chronic preoperative corticosteroid use was associated with a:
- 51% higher risk of postoperative VTE
- RR 1.51 (95% CI 1.31–1.73)
- 48% higher risk of deep vein thrombosis
- RR 1.48 (95% CI 1.19–1.84)
The association was particularly evident in colorectal surgery and lumbar/neurosurgical populations.
Importantly, these findings should not be interpreted as a call for automatic changes to thromboprophylaxis protocols.
The available evidence is observational, with important limitations – including residual confounding by steroid indication, dose, duration, comorbidity burden, and variations in prophylaxis practices.
Accordingly, certainty of evidence was low for composite VTE and DVT and very low for pulmonary embolism.
Nevertheless, the study highlights a practical perioperative question: should chronic corticosteroid exposure be more consistently documented and considered as part of individualized VTE risk assessment?
Future prospective studies should clarify how steroid indication, cumulative dose, treatment duration, and prophylaxis strategies influence postoperative thrombotic risk.”
Stay updated with Hemostasis Today.
-
Sep 15, 2026, 23:13Grace M Thomas: Join 3rd edition of the Neutrophil Club of SFI Webinar Series on Thromboinflammation
-
Sep 15, 2026, 23:05Noha K Hashmi: Honoured to Present 2 Case-Based Posters at the 5th MENA Conference for Rare Diseases 2026
-
Sep 15, 2026, 22:56Susan Slingluff Hartmann: How NBDF and the BDRC Are Putting Lived Experience at the Heart of Studies
-
Sep 15, 2026, 22:50Shehab Mohamed: New GCC Consensus Recommendations for the Diagnosis and Management of HLH
-
Sep 15, 2026, 22:42100 Years of von Willebrand Disease: What Has a Century of Progress Taught Us? – EAHAD
-
Sep 15, 2026, 22:38Cedric Hermans: How Iis TFPI Inhibition Changing Haemophilia Care?
-
Sep 15, 2026, 17:33Reza Shojaei: Blood and Plasma Donors Are Not a Production Metric
-
Sep 15, 2026, 17:32Thomas Dayspring: MHT for Vasomotor Symptoms May Also Offer Cardiovascular Benefits
-
Sep 15, 2026, 17:31Rebecca Risman: Deciphering the Mechanisms of Fibrinolysis in Contracted Clots